started · updated
Global Burden of Disease Study reports rising mental health disorders
The Global Burden of Disease Study reveals a significant increase in mental health disorders worldwide between 1990 and 2023. Data indicates that anxiety disorders rose by 45% and depressive disorders by 20% globally. In low- and middle-income countries (LMICs), anxiety disorders saw a 102.3% increase, while depressive disorders rose by 28.6%. The COVID-19 pandemic was identified as a factor that markedly exacerbated these trends.
Research suggests a strong link between metabolic health and mental illness. A meta-analysis of 120 studies found that individuals with severe mental illnesses are three times more likely to become obese than those without. Long-term monitoring of patients with schizophrenia and bipolar disorder showed that obesity rates rose significantly over a 20-year period following diagnosis. Additionally, children with autism spectrum disorders appear to have a 40% higher probability of developing obesity.
While psychiatric medications like antidepressants and antipsychotics are known to contribute to weight gain, researchers note that therapeutic treatments alone do not fully explain the correlation. The findings highlight a critical connection between metabolic disturbances, such as blood glucose fluctuations, and brain function, emphasizing the need for targeted public health interventions in resource-limited settings.